179 related articles for article (PubMed ID: 12920850)
1. 11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase).
Pomper MG; Musachio JL; Zhang J; Scheffel U; Zhou Y; Hilton J; Maini A; Dannals RF; Wong DF; Kozikowski AP
Mol Imaging; 2002; 1(2):96-101. PubMed ID: 12920850
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studies.
Pomper MG; Musachio JL; Scheffel U; Macdonald JE; McCarthy DJ; Reif DW; Villemagne VL; Yokoi F; Dannals RF; Wong DF
J Nucl Med; 2000 Aug; 41(8):1417-25. PubMed ID: 10945536
[TBL] [Abstract][Full Text] [Related]
3. Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA).
Rais R; Rojas C; Wozniak K; Wu Y; Zhao M; Tsukamoto T; Rudek MA; Slusher BS
J Pharm Biomed Anal; 2014 Jan; 88():162-9. PubMed ID: 24055700
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vivo evaluation and PET study of a carbon-11-labeled neuronal nitric oxide synthase (nNOS) inhibitor S-methyl-L-thiocitrulline.
Zhang J; Xu M; Dence CS; Sherman EL; McCarthy TJ; Welch MJ
J Nucl Med; 1997 Aug; 38(8):1273-8. PubMed ID: 9255165
[TBL] [Abstract][Full Text] [Related]
5. 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.
Chen Y; Pullambhatla M; Foss CA; Byun Y; Nimmagadda S; Senthamizhchelvan S; Sgouros G; Mease RC; Pomper MG
Clin Cancer Res; 2011 Dec; 17(24):7645-53. PubMed ID: 22042970
[TBL] [Abstract][Full Text] [Related]
6. [(18)F]Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ Clearance.
Chen Y; Lisok A; Chatterjee S; Wharram B; Pullambhatla M; Wang Y; Sgouros G; Mease RC; Pomper MG
Bioconjug Chem; 2016 Jul; 27(7):1655-62. PubMed ID: 27270097
[TBL] [Abstract][Full Text] [Related]
7. Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration.
Rais R; Wozniak K; Wu Y; Niwa M; Stathis M; Alt J; Giroux M; Sawa A; Rojas C; Slusher BS
PLoS One; 2015; 10(7):e0131861. PubMed ID: 26151906
[TBL] [Abstract][Full Text] [Related]
8. Binding of the glutamate carboxypeptidase II (NAALADase) inhibitor 2-PMPA to rat brain membranes.
Tiffany CW; Cai NS; Rojas C; Slusher BS
Eur J Pharmacol; 2001 Sep; 427(2):91-6. PubMed ID: 11557259
[TBL] [Abstract][Full Text] [Related]
9. The distribution of [11C]cocaine in normal and cocaine-sensitization mice.
Mizugaki M; Hishinuma T; Kimura K; Nakamura H; Aso H; Ishii F; Nishikawa M; Itoh K; Tomioka Y; Ishiwata S
Nucl Med Biol; 1994 Aug; 21(6):793-9. PubMed ID: 9234328
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta.
Thomas AG; Liu W; Olkowski JL; Tang Z; Lin Q; Lu XC; Slusher BS
Eur J Pharmacol; 2001 Oct; 430(1):33-40. PubMed ID: 11698060
[TBL] [Abstract][Full Text] [Related]
11. Carbon-11 labelled ketamine-synthesis, distribution in mice and PET studies in baboons.
Shiue CY; Vallabhahosula S; Wolf AP; Dewey SL; Fowler JS; Schlyer DJ; Arnett CD; Zhou YG
Nucl Med Biol; 1997 Feb; 24(2):145-50. PubMed ID: 9089707
[TBL] [Abstract][Full Text] [Related]
12. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).
Huang Y; Narendran R; Bae SA; Erritzoe D; Guo N; Zhu Z; Hwang DR; Laruelle M
Nucl Med Biol; 2004 Aug; 31(6):727-38. PubMed ID: 15246363
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.
Hillier SM; Maresca KP; Femia FJ; Marquis JC; Foss CA; Nguyen N; Zimmerman CN; Barrett JA; Eckelman WC; Pomper MG; Joyal JL; Babich JW
Cancer Res; 2009 Sep; 69(17):6932-40. PubMed ID: 19706750
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA).
Huang Y; Hwang DR; Zhu Z; Bae SA; Guo N; Sudo Y; Kegeles LS; Laruelle M
Nucl Med Biol; 2002 Oct; 29(7):741-51. PubMed ID: 12381454
[TBL] [Abstract][Full Text] [Related]
15. Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA.
Popik P; Kozela E; Wróbel M; Wozniak KM; Slusher BS
Neuropsychopharmacology; 2003 Mar; 28(3):457-67. PubMed ID: 12629525
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.
Zheng QH; Fei X; DeGrado TR; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Mock BH; Glick-Wilson BE; Sullivan ML; Miller KD; Sledge GW; Hutchins GD
Nucl Med Biol; 2003 Oct; 30(7):753-60. PubMed ID: 14499334
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.
Hashimoto H; Kawamura K; Igarashi N; Takei M; Fujishiro T; Aihara Y; Shiomi S; Muto M; Ito T; Furutsuka K; Yamasaki T; Yui J; Xie L; Ono M; Hatori A; Nemoto K; Suhara T; Higuchi M; Zhang MR
J Nucl Med; 2014 Sep; 55(9):1532-8. PubMed ID: 24963128
[TBL] [Abstract][Full Text] [Related]
18. N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.
Mease RC; Dusich CL; Foss CA; Ravert HT; Dannals RF; Seidel J; Prideaux A; Fox JJ; Sgouros G; Kozikowski AP; Pomper MG
Clin Cancer Res; 2008 May; 14(10):3036-43. PubMed ID: 18483369
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II.
Luthi-Carter R; Barczak AK; Speno H; Coyle JT
Brain Res; 1998 Jun; 795(1-2):341-8. PubMed ID: 9622670
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis and ex vivo evaluation of [11C]-SIB-1553A as a PET radiotracer for beta4 selective subtype nicotinic acetylcholine receptor.
Sobrio F; Quentin T; Dhilly M; Bourdier T; Tymciu S; Debruyne D; Barré L
Nucl Med Biol; 2008 Apr; 35(3):377-85. PubMed ID: 18355694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
